CTMX CYTOMX THERAPEUTICS INC Management Changes 8-K Filing 2024 - Appointment of CFO CytomX Therapeutics appointed Chris Ogden as Chief Financial Officer, with no significant transactions or relationships requiring disclosure.Get access to all SEC 8-K filings of the CYTOMX THERAPEUTICS INC